Efficacy of Combined iStent Inject (R) with Phacoemulsification for Intraocular Pressure Lowering in Asian Subjects with Glaucoma

Hu Jeremy Youwei; Ang Bryan; Yip Leonard Wei Leon

首页> 外文期刊>Investigative ophthalmology & visual science >Efficacy of Combined iStent Inject (R) with Phacoemulsification for Intraocular Pressure Lowering in Asian Subjects with Glaucoma

【24h】

Efficacy of Combined iStent Inject (R) with Phacoemulsification for Intraocular Pressure Lowering in Asian Subjects with Glaucoma

机译：组合含量注射（R）与青光眼亚洲受试者中眼压降低的术治疗术治疗的疗效

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Investigative ophthalmology & visual science 》 |2018年第9期| 共2页
作者
Hu Jeremy Youwei; Ang Bryan; Yip Leonard Wei Leon;
展开▼
作者单位

Tan Tock Seng Hosp Ophthalmol Singapore Singapore;

Tan Tock Seng Hosp Ophthalmol Singapore Singapore;

Tan Tock Seng Hosp Ophthalmol Singapore Singapore;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy of Combined iStent Inject (R) with Phacoemulsification for Intraocular Pressure Lowering in Asian Subjects with Glaucoma [J] . Hu Jeremy Youwei, Ang Bryan, Yip Leonard Wei Leon Investigative ophthalmology & visual science . 2018 ,第9期

机译：组合含量注射（R）与青光眼亚洲受试者中眼压降低的术治疗术治疗的疗效
2. Combined iStent ? Inject Trabecular Micro-Bypass and Phacoemulsification in Australian Patients with Open-Angle Glaucoma [J] . Alon M Salby, Simon E Skalicky Clinical ophthalmology . 2020 ,第4期

机译：结合了吗？在澳大利亚开放角度青光眼患者中注入小梁微旁路和沉重乳化
3. Long-term Safety and Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: the JUPITER Study [J] . Kawase Kazuhide, Vittitow Jason L., Yamamoto Tetsuya, Investigative ophthalmology & visual science . 2016 ,第12期

机译：长期安全和眼内压力降低Latanoprostene Bue 0.024％的日本受试者的疗效，带有开口角度青光眼或眼高血压：木星研究
4. Changes in Intraocular Pressure, Ocular Perfusion Pressure and Blood Flow Fluctuations during Dorzolamide vs Timolol Add-on Therapies in Glaucoma Patients Previously Treated with Prostaglandin Analogue [C] . Siaudvytyte L., Januleviciene I., Barsauskaite R., International Symposium on Ocular Pharmacology and Therapeutics . 2011

机译：含有前列腺素患者的多唑胺患者中的眼内压，眼灌注压力和血流波动的变化，前列腺素相似
5. Long Term Intraocular Pressure (IOP) Lowering Effect of Femtosecond Laser Assisted Cataract Surgery (FLACS) Versus Conventional Phacoemulsification (PE) [D] . Ataei, Yasaman. 2020

机译：长期眼内压（IOP）对飞秒激光辅助白内障手术（FLACS）对常规沉默乳化的降低效果（PE）
6. Combined iStent®Inject Trabecular Micro-Bypass and Phacoemulsification in Australian Patients with Open-Angle Glaucoma [O] . Alon M Salby, Simon E Skalicky 2020

机译：结合iStent®在澳大利亚开角型青光眼患者中注射小梁微旁路和超声乳化术
7. >Combined iStent® Inject Trabecular Micro-Bypass and Phacoemulsification in Australian Patients with Open-Angle Glaucoma [O] . Alon M Salby, Simon E Skalicky 2020

机译：>在澳大利亚开放角度青光眼患者中，在澳大利亚患者中施用>β® 注入术前微旁路和沉重乳化

1. 持续性高眼压青光眼的抗青光眼手术实际临床治疗效果 [J] . 张小蓉 ,郭建波 . 系统医学 . 2019 ,第010期

2. 持续性高眼压青光眼的抗青光眼手术实际临床治疗效果 [J] . 张小蓉1 ,郭建波1 . 系统医学 . 2019 ,第010期

3. 抗青光眼手术治疗高眼压性青光眼的疗效探讨 [J] . 林英跃 ,梁超 . 中国实用医药 . 2018 ,第016期

4. 抗青光眼手术治疗持续性高眼压青光眼的临床疗效分析 [J] . 王媛 . 现代诊断与治疗 . 2017 ,第007期

5. 选择性激光小梁成形术与抗青光眼药物治疗青光眼和高眼压症疗效的Meta分析 [J] . 魏雅慧 ,李雪迎 ,才瑜 . 中华实验眼科杂志 . 2016 ,第011期

6. 超声乳化并人工晶状体植入术治疗抗青光眼术后眼压控制不佳白内障患者的临床效果 [C] . 魏捷 ,蒋华 ,高洪瑞 . 山东省第十九次眼科学学术会议 . 2015

7. 选择性激光小梁成形术治疗开角型青光眼和高眼压症的疗效观察 [A] . 陈菂 . 2013

1. 三唑并喹唑啉和吡唑并三唑并嘧啶衍生物、医药组合物、腺苷 A 3受体亲和剂、降眼压剂、预防和治疗青光眼的制剂及降低眼压的方法 [P] . 中国专利： CN1491227A . 2004-04-21

2. 用于治疗青光眼或高眼压症的包含眼内压降低剂、CNP化合物、NPR-B化合物、TIE-2激动剂或神经营养剂的缓释药物递送系统 [P] . 中国专利： CN112566622A . 2021-03-26

3. Triazoloquinazoline and pyrazolotriazolopyrimidine derivatives, pharmaceutical compositions, adenosine A3 receptor affinity agents, intraocular pressure lowering agents, preparations for prevention and treatment of glaucoma, and methods for lowering intraocular pressure [P] . 外国专利： JPWO2002062801A1 . 2004-06-10

机译：三唑并喹唑啉和吡唑并三唑并嘧啶衍生物，药物组合物，腺苷A3受体亲和剂，眼内压降低剂，预防和治疗青光眼的制剂以及降低眼内压的方法

4. NORMAL INTRAOCULAR PRESSURE GLAUCOMA MODEL AND EVALUATION METHOD OF PREVENTION OR THERAPEUTIC EFFECT FOR NORMAL INTRAOCULAR PRESSURE GLAUCOMA OF EVALUATION TARGET MEDICINE [P] . 外国专利： JP2019216636A . 2019-12-26

机译：正常眼压性青光眼模型及评估方法对正常眼压性青光眼的预防或治疗效果评估方法

5. DRUG DELIVERY SYSTEMS COMPRISING AN INTRAOCULAR PRESSURE LOWERING AGENT, A NEUROTROPHIC AGENT, A C-TYPE NATRIURETIC PEPTIDE, A NATRIURETIC PEPTIDE RECEPTOR-B, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR OR A FAS-LIGAND INHIBITOR FOR TREATING GLAUCOMA OR OCULAR HYPERTENSION [P] . 外国专利： WO2021127124A1 . 2021-06-24

机译：药物递送系统，包括眼压降低剂，神经营养剂，C型NaTrietic肽，Natrietic肽受体-B，用于治疗青光眼或眼高血压的凋亡信号传导片段抑制剂或Fas-Ligand抑制剂

相关主题

Efficacy of Combined iStent Inject (R) with Phacoemulsification for Intraocular Pressure Lowering in Asian Subjects with Glaucoma

著录项

相似文献

相关主题

期刊订阅